The effects of nanoparticle drug loading on the pharmacokinetics of anticancer agents
出版年份 2015 全文链接
标题
The effects of nanoparticle drug loading on the pharmacokinetics of anticancer agents
作者
关键词
-
出版物
Nanomedicine
Volume 10, Issue 3, Pages 447-463
出版商
Future Medicine Ltd
发表日期
2015-02-24
DOI
10.2217/nnm.14.179
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The evaluation of gender on the pharmacokinetics (PK) of pegylated liposomal anticancer agents.
- (2017) N. M. La-Beck et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of geriatric vulnerability parameters on pegylated liposomal doxorubicin (PLD) tolerance and outcome in elderly patients with metastatic breast cancer: Results of the DOGMES multicenter phase II GINECO trial.
- (2017) C. Falandry et al. JOURNAL OF CLINICAL ONCOLOGY
- Synergy of Nab-paclitaxel and Bevacizumab in Eradicating Large Orthotopic Breast Tumors and Preexisting Metastases
- (2015) Lisa D. Volk et al. NEOPLASIA
- Age affects pegylated liposomal doxorubicin elimination and tolerability in patients over 70 years old
- (2014) Milena Gusella et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)
- (2014) Pieter J. Gaillard et al. PLoS One
- Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacy
- (2013) Kevin S. Chu et al. BIOMATERIALS
- Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
- (2013) U. Prabhakar et al. CANCER RESEARCH
- Meta-analysis of inter-patient pharmacokinetic variability of liposomal and non-liposomal anticancer agents
- (2013) Ryan F. Schell et al. Nanomedicine-Nanotechnology Biology and Medicine
- Strategies for advancing cancer nanomedicine
- (2013) Vikash P. Chauhan et al. NATURE MATERIALS
- Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer
- (2013) Carey K. Anders et al. PLoS One
- Combining two strategies to improve perfusion and drug delivery in solid tumors
- (2013) T. Stylianopoulos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma
- (2013) S. A. Jensen et al. Science Translational Medicine
- Interpatient Pharmacokinetic and Pharmacodynamic Variability of Carrier-Mediated Anticancer Agents
- (2012) W P Caron et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Recent advances in brain tumor-targeted nano-drug delivery systems
- (2012) Yu Liu et al. Expert Opinion on Drug Delivery
- Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft
- (2012) Kevin S. Chu et al. Nanomedicine-Nanotechnology Biology and Medicine
- Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients
- (2011) Ninh M. La-Beck et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Population Pharmacokinetics of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies
- (2011) Huali Wu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)
- (2010) C. Rochlitz et al. ANNALS OF ONCOLOGY
- Bidirectional pharmacodynamic interaction between pegylated liposomal CKD-602 (S-CKD602) and monocytes in patients with refractory solid tumors
- (2010) William C. Zamboni et al. JOURNAL OF LIPOSOME RESEARCH
- Pharmacokinetic Study of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies
- (2009) W C Zamboni et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development
- (2008) Daryl C. Drummond et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Pharmacokinetics and Biodistribution of Nanoparticles
- (2008) Shyh-Dar Li et al. MOLECULAR PHARMACEUTICS
- Preclinical Studies To Understand Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle Biodistribution
- (2008) Marina A. Dobrovolskaia et al. MOLECULAR PHARMACEUTICS
- Concept and Clinical Evaluation of Carrier-Mediated Anticancer Agents
- (2008) W. C. Zamboni ONCOLOGIST
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started